All Relations between Acromegaly and gh

Publication Sentence Publish Date Extraction Date Species
S W Lamberts, M Zweens, J G Klijn, C C van Vroonhoven, S Z Stefanko, E Del Poz. The sensitivity of growth hormone and prolactin secretion to the somatostatin analogue SMS 201-995 in patients with prolactinomas and acromegaly. Clinical endocrinology. vol 25. issue 2. 1987-02-05. PMID:2878748. in the present study it was investigated whether prl release in prolactinoma and acromegalic patients might also be sensitive to sms 201-995 and whether co-secretion of prl in acromegaly plays a role in determining the sensitivity of gh secretion to sms 201-995. 1987-02-05 2023-08-11 Not clear
T Karashima, K Kato, H Nawata, S Ikuyama, H Ibayashi, H Nakagaki, K Kitamur. Postoperative plasma GH levels and restoration of GH dynamics in acromegalic patients surgically treated by the transsphenoidal approach. Clinical endocrinology. vol 25. issue 2. 1987-02-05. PMID:3791660. in 44 patients with acromegaly treated by transsphenoidal pituitary microsurgery, the relationship between changes in pre- and post-operative gh dynamics and postoperative fasting plasma gh levels was examined to clarify which is the optimal approach for evaluating postoperative removal of the tumour. 1987-02-05 2023-08-11 Not clear
R J Comi, P Gorde. The response of serum growth hormone levels to the long-acting somatostatin analog SMS 201-995 in acromegaly. The Journal of clinical endocrinology and metabolism. vol 64. issue 1. 1987-01-16. PMID:2878009. we studied the effect of sms (50-100 micrograms, sc, every 8 h) on serum gh in five patients with acromegaly. 1987-01-16 2023-08-11 Not clear
R J Comi, P Gorde. The response of serum growth hormone levels to the long-acting somatostatin analog SMS 201-995 in acromegaly. The Journal of clinical endocrinology and metabolism. vol 64. issue 1. 1987-01-16. PMID:2878009. these results indicate that sms-induced reductions in serum gh in patients with acromegaly are often not sustained despite sms administration every 8 h and indicate that the insufficient duration of effect may limit its therapeutic efficacy. 1987-01-16 2023-08-11 Not clear
G Oppizzi, M M Petroncini, D Dallabonzana, R Cozzi, G Verde, P G Chiodini, A Liuzz. Relationship between somatomedin-C and growth hormone levels in acromegaly: basal and dynamic evaluation. The Journal of clinical endocrinology and metabolism. vol 63. issue 6. 1986-12-29. PMID:2878007. our data indicate an overall dependency of plasma smc levels on plasma gh levels in acromegaly, although similar gh levels may have differing somatomedin-stimulating activities. 1986-12-29 2023-08-11 Not clear
G Oppizzi, M M Petroncini, D Dallabonzana, R Cozzi, G Verde, P G Chiodini, A Liuzz. Relationship between somatomedin-C and growth hormone levels in acromegaly: basal and dynamic evaluation. The Journal of clinical endocrinology and metabolism. vol 63. issue 6. 1986-12-29. PMID:2878007. in evaluating pharmacological or surgical treatments of acromegaly, a single plasma smc value can reliably replace several plasma gh determinations. 1986-12-29 2023-08-11 Not clear
K A Roth, D M Wilson, J Eberwine, R I Dorin, K Kovacs, K G Bensch, A R Hoffma. Acromegaly and pheochromocytoma: a multiple endocrine syndrome caused by a plurihormonal adrenal medullary tumor. The Journal of clinical endocrinology and metabolism. vol 63. issue 6. 1986-12-29. PMID:3097056. these findings indicate that gh excess accompanied by somatotroph hyperplasia and acromegaly were secondary to a pheochromocytoma which secreted not only catecholamines but also ghrh. 1986-12-29 2023-08-11 Not clear
A L Barkan, Y Shenker, R J Grekin, W W Vale, R V Lloyd, T F Beal. Acromegaly due to ectopic growth hormone (GH)-releasing hormone (GHRH) production: dynamic studies of GH and ectopic GHRH secretion. The Journal of clinical endocrinology and metabolism. vol 63. issue 5. 1986-11-19. PMID:3093517. acromegaly due to ectopic growth hormone (gh)-releasing hormone (ghrh) production: dynamic studies of gh and ectopic ghrh secretion. 1986-11-19 2023-08-11 Not clear
A L Barkan, Y Shenker, R J Grekin, W W Vale, R V Lloyd, T F Beal. Acromegaly due to ectopic growth hormone (GH)-releasing hormone (GHRH) production: dynamic studies of GH and ectopic GHRH secretion. The Journal of clinical endocrinology and metabolism. vol 63. issue 5. 1986-11-19. PMID:3093517. dynamic studies of gh and gh-releasing hormone (ghrh) secretion were performed in a man with a ghrh-producing carcinoid tumor and acromegaly. 1986-11-19 2023-08-11 Not clear
A L Barkan, Y Shenker, R J Grekin, W W Vale, R V Lloyd, T F Beal. Acromegaly due to ectopic growth hormone (GH)-releasing hormone (GHRH) production: dynamic studies of GH and ectopic GHRH secretion. The Journal of clinical endocrinology and metabolism. vol 63. issue 5. 1986-11-19. PMID:3093517. we conclude that prolonged exposure of the pituitary gland to high concentrations of ghrh is associated with chronic gh hypersecretion and may be accompanied by a preserved acute gh response to exogenous ghrh; a paradoxical response of gh to trh may be mediated at the pituitary level, consequent to prolonged pituitary exposure to ghrh; bromocriptine suppression of gh in acromegaly is due to a direct pituitary effect of the drug; and somatostatin inhibits both ectopic ghrh secretion as well as gh responsiveness to ghrh in vivo. 1986-11-19 2023-08-11 Not clear
A L Barkan, Y Shenker, R J Grekin, W W Vale, R V Lloyd, T F Beal. Acromegaly due to ectopic growth hormone (GH)-releasing hormone (GHRH) production: dynamic studies of GH and ectopic GHRH secretion. The Journal of clinical endocrinology and metabolism. vol 63. issue 5. 1986-11-19. PMID:3093517. since gh secretory responses in patients with somatotroph adenomas are similar to those in this patient, augmented ghrh secretion may play a role in development of the "classic" form of acromegaly. 1986-11-19 2023-08-11 Not clear
V Jordan, C Dieguez, R Valcavi, C Artioli, I Portioli, M D Rodriguez-Arnao, A Gomez-Pan, R Hall, M F Scanlo. Lack of effect of muscarinic cholinergic blockade on the GH responses to GRF 1-29 and TRH in acromegalic subjects. Clinical endocrinology. vol 24. issue 4. 1986-10-23. PMID:2874906. cholinergic muscarinic blockade did not alter the gh responses to grf and trh in patients with acromegaly. 1986-10-23 2023-08-11 human
I A MacFarlane, S Stafford, A D Wrigh. Circulating growth hormone forms in type 1 diabetic subjects: comparison with normal subjects and acromegalics. Acta endocrinologica. vol 112. issue 4. 1986-10-16. PMID:3751466. the sustained release of gh found in acromegaly is composed largely of monomeric forms. 1986-10-16 2023-08-11 human
G Sassolas, J Garry, R Cohen, H Bastuji, E Vermeulen, P Cabrera, B Roussel, M Jouve. Nocturnal continuous infusion of growth hormone (GH)-releasing hormone results in a dose-dependent accentuation of episodic GH secretion in normal men. The Journal of clinical endocrinology and metabolism. vol 63. issue 4. 1986-10-15. PMID:3091627. fluctuations in plasma gh levels have been found in patients with acromegaly who have continuously elevated levels of ectopically produced gh-releasing hormone (ghrh). 1986-10-15 2023-08-11 human
I Jialal, K Reddi, M A Omar, J R Van Dellen, S M Jouber. Pituitary tumours in African and Indian patients. Tropical and geographical medicine. vol 38. issue 2. 1986-09-23. PMID:3738985. of the 33 patients with secretory tumours 20 had gh-secreting tumours (acromegaly), 8 prolactinomas and 5 acth-producing tumours (cushing's disease); in addition 4 of the patients with acromegaly probably had combined gh and prolactin secreting tumours. 1986-09-23 2023-08-11 Not clear
A Zárate, I C García, C Morán, M E Fonsec. Impaired glucose tolerance coincides with abnormal release of growth hormone following a glucose load as well as in response to TRH in acromegaly. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme. vol 18. issue 6. 1986-09-17. PMID:3089892. we have attempted to investigate a relationship between the paradoxical gh secretion with the abnormal glucose tolerance test present in some cases of acromegaly. 1986-09-17 2023-08-11 Not clear
P Pietschmann, G Schernthaner, A Luge. Effect of cholinergic muscarinic receptor blockade on human growth hormone (GH)-releasing hormone-(1-44)-induced GH secretion in acromegaly and type I diabetes mellitus. The Journal of clinical endocrinology and metabolism. vol 63. issue 2. 1986-08-14. PMID:3088023. effect of cholinergic muscarinic receptor blockade on human growth hormone (gh)-releasing hormone-(1-44)-induced gh secretion in acromegaly and type i diabetes mellitus. 1986-08-14 2023-08-11 human
M Losa, J Schopohl, A König, O A Müller, K von Werde. Growth hormone (GH) and prolactin responses to repetitive administration of GH-releasing hormone in acromegaly. The Journal of clinical endocrinology and metabolism. vol 63. issue 2. 1986-08-14. PMID:3088026. growth hormone (gh) and prolactin responses to repetitive administration of gh-releasing hormone in acromegaly. 1986-08-14 2023-08-11 human
M Losa, J Schopohl, A König, O A Müller, K von Werde. Growth hormone (GH) and prolactin responses to repetitive administration of GH-releasing hormone in acromegaly. The Journal of clinical endocrinology and metabolism. vol 63. issue 2. 1986-08-14. PMID:3088026. we investigated the pattern of gh secretion in response to repetitive gh-releasing hormone (ghrh) administration in patients with active acromegaly and in normal subjects. 1986-08-14 2023-08-11 human
M Losa, J Schopohl, A König, O A Müller, K von Werde. Growth hormone (GH) and prolactin responses to repetitive administration of GH-releasing hormone in acromegaly. The Journal of clinical endocrinology and metabolism. vol 63. issue 2. 1986-08-14. PMID:3088026. thus, patients with active acromegaly, but not normal subjects, respond to repetitive ghrh administration at 2-h intervals with an increase in gh levels. 1986-08-14 2023-08-11 human